Hence, empagliflozin is not commonly used as a routine treatment for type 1 diabetes but is mainly approved to treat type 2 diabetes
Saad AA, Ashcroft DM, Watson KD, Hyrich KL, Noyce PR, Symmons DP
For these patients, greater muscle loss was also tied to weaker improvements in their blood sugar, measured through HbA1c levelsa key marker for blood sugar control over time
Semaglutide, the drug best known for its effectiveness in weight loss and diabetes management, may have another surprising benefit: reducing alcohol consumption and cravings
Theodoropoulos DS, Krasnewich D, Kaiser-Kupfer MI, Gahl WA (1993) Classic nephropathic cystinosis as an adult disease
No social factors clearly contributed to poor adherence